CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $14,000 | -82.5% | 1,951 | -79.8% | 0.00% | -66.7% |
| Q1 2022 | $80,000 | +100.0% | 9,670 | +63.0% | 0.00% | +200.0% |
| Q4 2021 | $40,000 | +135.3% | 5,932 | +84.3% | 0.00% | 0.0% |
| Q3 2021 | $17,000 | +750.0% | 3,219 | +469.7% | 0.00% | – |
| Q3 2020 | $2,000 | -84.6% | 565 | -83.9% | 0.00% | -100.0% |
| Q4 2019 | $13,000 | – | 3,517 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |